-Dow Jones
Janssen’s Darzalex Faspro Wins FDA Approval In Combination With Pomalidomide, Dexamethasone For Multiple Myeloma
The FDA has approved Janssen Biotech Inc’s, a unit of Johnson & Johnson (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for multiple myeloma…